Simultaneous Two-Directional Catalytic Radical Cross-Coupling
ACS Applied Catalysis · 2026
DOI: 10.1021/acsappcat.6c00118 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Catalysis, 2026. Verfasst von Joshua O. Imasuen und 9 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Gefördert von: AbbVie, NSF Center for Synthetic Organic Electrochemistry, University of Utah.
Abstract (Originalsprache)
Two-directional synthesis is a powerful strategy for rapidly increasing molecular complexity, yet its tactical implementation with radical cross-coupling remains underdeveloped. Here, we report simultaneous two-directional radical cross-coupling of bifunctional radical precursors. Diacid-derived bis-redox-active esters undergo Ag–Ni electrocatalytic decarboxylative arylation to access functionalized dibenzyl amines and related linkers, while diamine-derived bis-sulfonyl hydrazides participate in redox-neutral deaminative RCC. This strategy enables chemoselective, scalable access to valuable products from readily available starting materials.
Förderung
- AbbVie
- NSF Center for Synthetic Organic Electrochemistry, University of Utah
Zitieren
APA
Imasuen, J. O., Jiang, B., Sofiadis, M., Harper, K. C., Yamamoto, D., Imai, T., Pollatos, A. S., Neigenfind, P., Kawamata, Y., & Baran, P. S. (2026). Simultaneous Two-Directional Catalytic Radical Cross-Coupling. ACS Applied Catalysis. https://doi.org/10.1021/acsappcat.6c00118
Vancouver
Imasuen JO, Jiang B, Sofiadis M, Harper KC, Yamamoto D, Imai T, et al. Simultaneous Two-Directional Catalytic Radical Cross-Coupling. ACS Applied Catalysis. 2026. doi:10.1021/acsappcat.6c00118
BibTeX
@article{Imasuen2026,
author = {Imasuen, Joshua O. and Jiang, Baiyang and Sofiadis, Manolis and Harper, Kaid C. and Yamamoto, Daiki and Imai, Tomoya and Pollatos, Alexandros S. and Neigenfind, Philipp and Kawamata, Yu and Baran, Phil S.},
title = {Simultaneous Two-Directional Catalytic Radical Cross-Coupling},
journal = {ACS Applied Catalysis},
year = {2026},
doi = {10.1021/acsappcat.6c00118}
}
EUVIMED